MicroConstants Blog Immunogenicity Testing For Biosimilars

Entering the biosimilars market is an enticing prospect for many biopharma companies, offering the potential for reduced development and manufacturing costs while providing patients with broader access to critical medicines. The recent boom in the biosimilars market seen following a wave of blockbuster molecules coming off patent between 2015 and 2020 demonstrates the powerful allure [...]Share ThisThe post Immunogenicity Testing For Biosimilars appeared first on Bioanalytical Lab & Top CRO for Large Molecule Bioanalysis.